Risk of amoxicillin-related renal adverse events in high-dose therapy: a real-world pharmacovigilance study based on FAERS
Medical Journal of Chinese People′s Liberation ArmyVol. 51, Issue 1, Pages: 56-64(2026)
Clinical Research|更新时间:2026-03-04
分享给微信好友或者朋友圈
导出参考文献
Risk of amoxicillin-related renal adverse events in high-dose therapy: a real-world pharmacovigilance study based on FAERS
增强出版
“The latest research focuses on the risk of amoxicillin induced kidney damage. Experts have analyzed massive amounts of data and found that advanced age, high body weight, intravenous administration, long course of treatment, and high dosage are key risk factors, sounding the alarm for safe clinical medication.”
Chen Lei-Lei,Zhang Tian-Yi,Zhai Wen-Jing,et al.Risk of amoxicillin-related renal adverse events in high-dose therapy: a real-world pharmacovigilance study based on FAERS[J].Medical Journal of Chinese People′s Liberation Army,2026,51(01):56-64.
Chen Lei-Lei,Zhang Tian-Yi,Zhai Wen-Jing,et al.Risk of amoxicillin-related renal adverse events in high-dose therapy: a real-world pharmacovigilance study based on FAERS[J].Medical Journal of Chinese People′s Liberation Army,2026,51(01):56-64. DOI: 10.11855/j.issn.0577-7402.1208.2025.1027.
Risk of amoxicillin-related renal adverse events in high-dose therapy: a real-world pharmacovigilance study based on FAERS增强出版